Dr. Marty Makary, John Hopkins surgeon and NYT bestselling author, joins " Live Sunday" to discuss the realities of using the ...

Nearly 4.4 million adult New Yorkers, or 30%, have obesity, but access to weight-loss medications varies based on a variety ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn't ...

Ozempic and Wegovy are branded versions of semaglutide made by pharmaceutical company Novo Nordisk. Ozempic has been ...

The Danish-based company has just revealed preliminary data suggesting that its experimental drug amycretin can help people ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of ...

Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo ...